Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference43 articles.
1. Evolving Chemotherapy for Advanced Gastric Cancer
2. Current status and future prospects of chemotherapy for metastatic gastric cancer: a review
3. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients
4. 5-Fluorouracil: mechanisms of action and clinical strategies
5. Chapter 3. Anti-Growth Effects
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review;Recent Patents on Anti-Cancer Drug Discovery;2022-02
2. A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer;Translational Oncology;2021-01
3. Inhibitory Effect of Chitosan Loaded 5-Fluorouracil Nanoparticles on Colon Cancer in Mice;NANOSCI NANOTECH LET;2020
4. Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer;Journal of Cancer;2019
5. Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase;Cancer Drug Resistance;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3